Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VaccinDirekt i Sverige AB
AB
Active
Org 5565631024
Olof Palmes Gata 13, 111 37
Stockholm
General medical practice activities
· NACE 8621
Est. 1998
181 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
VaccinDirekt i Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
138M
275M
413M
551M
172M
2020
242M
2021
329M
2022
415M
2023
479M
2024
EBITDA
SEK millions
0M
24M
48M
72M
95M
13M
2020
26M
2021
74M
2022
83M
2023
61M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
171 543
241 927
329 180
414 643
479 175
Staff expenses
—
—
—
—
—
EBITDA
12 930
25 926
73 825
82 907
60 846
Depreciation & amort.
−2 397
−2 668
−3 240
−4 074
−4 739
EBIT
10 533
23 258
70 585
78 833
56 107
Net financials
−113
−9 516
−171
1 620
6 065
Profit before tax
880
5 125
36 994
45 453
6 170
Tax
−358
−2 055
−7 673
−9 492
−357
Net profit
522
3 070
29 321
35 961
5 813
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
55 783
65 008
106 316
174 119
173 719
Equity
10 356
13 426
42 747
78 708
80 851
Long-term debt
0
0
0
1 400
1 885
Short-term debt
39 369
42 914
43 579
59 021
58 493
Total debt
39 369
42 914
43 579
60 421
60 378
Financial ratios
5-year trend
EBITDA margin
12.7%
This company
15.8%
Market median
-20% vs market
2020
2024
Equity ratio
46.5%
This company
38.2%
Market median
+22% vs market
2020
2024
Return on equity
7.2%
This company
18.4%
Market median
-61% vs market
2020
2024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
2020
2024
Asset turnover
2.76×
This company
1.12×
Market median
+146% vs market
2020
2024
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on VaccinDirekt i Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
